Advisors Preferred’s Medpace MEDP Stock Holding History

Advisors Preferred’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,575	Closed	-$132K	–	288
2019 Q3	$132K	Buy	+1,575	New	+$119K	0.03%	102

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Advisors Preferred's MEDP Position: Q4 2019 in Review

Advisors Preferred sold out of Medpace (MEDP) in Q4 2019, closing a stake of 1,575 shares — an estimated $132K sold.

Advisors Preferred first reported a position in MEDP in Q3 2019 and held it in 1 quarter. The position peaked at $132K in Q3 2019. 250 funds tracked by Wall St. Rank hold MEDP as of Q4 2019.

Advisors Preferred reported no remaining Medpace position as of Q4 2019 after selling out during the quarter.
Advisors Preferred sold 1,575 Medpace shares in Q4 2019, an estimated $132K.
Advisors Preferred first reported a position in Medpace in Q3 2019 and held it in 1 quarter.
Advisors Preferred's Medpace position peaked at $132K in Q3 2019.
250 funds tracked by Wall St. Rank held Medpace as of Q4 2019.

Based on Advisors Preferred's 13F filing for Q4 2019, filed 21 Jan 2020.